Assignee
ACADIA PHARM INC
US·84 granted patents·39 pending applications·1,730 citations·filing 1997–2025
Top patents by PatentIndex Score
123 records- 0198US8921393B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 30, 2014·41 cites·36 claims
- 0297US10028944B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2017·Granted Jul 24, 2018·15 cites·15 claims
- 0397US9566271B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 0497US8377959B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2012·Granted Feb 19, 2013·26 cites·12 claims
- 0597US8008323B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 30, 2011·25 cites·9 claims
- 0697US7994193B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 9, 2011·29 cites·9 claims
- 0797US7732462B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Jun 8, 2010·36 cites·24 claims
- 0897US7659285B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Feb 9, 2010·33 cites·11 claims
- 0997US7601740B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·26 claims
- 1097US6911452B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2002·Granted Jun 28, 2005·90 cites·16 claims
- 1196US10525046B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2018·Granted Jan 7, 2020·12 cites·20 claims
- 1296US9211289B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2014·Granted Dec 15, 2015·20 cites·13 claims
- 1396US7713995B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted May 11, 2010·30 cites·15 claims
- 1496US6815458B2Azacyclic compoundsACADIA PHARM INC·Filed 2001·Granted Nov 9, 2004·85 cites·48 claims
- 1596US6756393B2Azacyclic compoundsACADIA PHARM INC·Filed 2003·Granted Jun 29, 2004·77 cites·5 claims
- 1695US11161826B2Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agentACADIA PHARM INC·Filed 2020·Granted Nov 2, 2021·3 cites·6 claims
- 1795US9296694B2Azacyclic compoundsACADIA PHARM INC·Filed 2015·Granted Mar 29, 2016·17 cites·4 claims
- 1895US8618130B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 31, 2013·25 cites·15 claims
- 1995US7868176B2Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparationACADIA PHARM INC·Filed 2005·Granted Jan 11, 2011·33 cites·16 claims
- 2095US7863296B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2005·Granted Jan 4, 2011·47 cites·18 claims
- 2194US10981870B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic formACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·12 claims
- 2294US10981871B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·13 claims
- 2394US10849891B2Formulations of pimavanserinACADIA PHARM INC·Filed 2020·Granted Dec 1, 2020·8 cites·15 claims
- 2494US10449185B2Formulations of pimavanserinACADIA PHARM INC·Filed 2019·Granted Oct 22, 2019·12 cites·5 claims
- 2594US7923564B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2010·Granted Apr 12, 2011·26 cites·6 claims
- 2694US7875632B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2009·Granted Jan 25, 2011·23 cites·11 claims
- 2794US7732615B2N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2005·Granted Jun 8, 2010·29 cites·24 claims
- 2894US7351707B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2006·Granted Apr 1, 2008·22 cites·23 claims
- 2994US7217719B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2005·Granted May 15, 2007·24 cites·35 claims
- 3094US6951849B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2003·Granted Oct 4, 2005·44 cites·21 claims
- 3193US10646480B2Formulations of pimavanserinACADIA PHARM INC·Filed 2019·Granted May 12, 2020·9 cites·20 claims
- 3293US10597363B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2016·Granted Mar 24, 2020·10 cites·15 claims
- 3393US7790899B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2007·Granted Sep 7, 2010·32 cites·9 claims
- 3493US7538222B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2005·Granted May 26, 2009·19 cites·24 claims
- 3593US7491715B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2006·Granted Feb 17, 2009·32 cites·19 claims
- 3693US6528529B1Compounds with activity on muscarinic receptorsACADIA PHARM INC·Filed 1999·Granted Mar 4, 2003·195 cites·88 claims
- 3793US5955281AIdentification of ligands by selective amplification of cells transfected with receptorsACADIA PHARM INC·Filed 1997·Granted Sep 21, 1999·103 cites·13 claims
- 3893US5912132AIdentification of ligands by selective amplification of cells transfected with receptorsACADIA PHARM INC·Filed 1997·Granted Jun 15, 1999·103 cites·14 claims
- 3992US11827600B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2022·Granted Nov 28, 2023·3 cites·19 claims
- 4092US10517860B2Combination of pimavanserin and cytochrome P450 modulatorsACADIA PHARM INC·Filed 2019·Granted Dec 31, 2019·11 cites·5 claims
- 4191US7476682B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2006·Granted Jan 13, 2009·23 cites·50 claims
- 4291US7087593B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2002·Granted Aug 8, 2006·34 cites·19 claims
- 4390US11452721B2Formulations of pimavanserinACADIA PHARM INC·Filed 2022·Granted Sep 27, 2022·1 cites·13 claims
- 4490US7517871B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2006·Granted Apr 14, 2009·17 cites·21 claims
- 4589US7300928B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2006·Granted Nov 27, 2007·7 cites·21 claims
- 4689US7268232B2Androgen receptor modulators and method of treating disease using the sameACADIA PHARM INC·Filed 2005·Granted Sep 11, 2007·26 cites·10 claims
- 4788US9757366B2Methods for the treatment of parkinson's disease psychosis using pimavanserinACADIA PHARM INC·Filed 2016·Granted Sep 12, 2017·14 cites·6 claims
- 4888US7622461B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2007·Granted Nov 24, 2009·12 cites·26 claims
- 4988US7511053B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2007·Granted Mar 31, 2009·7 cites·24 claims
- 5088US7291611B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2005·Granted Nov 6, 2007·6 cites·23 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →